Scleroderma trials recruiting in Iowa

Fewer than 3 recruiting trials found.

All Scleroderma trials nationally

1

Recruiting in Iowa

1

Cities with sites

Cities in Iowa

Iowa City 1

Recruiting trials in Iowa

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Iowa: Iowa City

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.